"Commenting on the Company’s outlook for the remainder of FY2016, Mr Wilson said:
“With increased stability post Gemalto’s sales restructure and the completion of delayed product sales during the second half of FY2016 Senetas expects higher revenue and profit than the first half of FY2016. Current expectations are that Profit Before Tax for the second half of FY2016 will be similar to or slightly higher than the prior corresponding period which would result in a Net Profit Before Tax of approximately $5 million for the full year to 30 June 2016."
Looks good!
- Forums
- ASX - By Stock
- SEN
- Ann: Appendix 4D and Half Year Financial Report
Ann: Appendix 4D and Half Year Financial Report, page-6
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SEN (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.14M |
Open | High | Low | Value | Volume |
2.3¢ | 2.3¢ | 2.2¢ | $196 | 8.849K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 17826 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 52 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 17826 | 0.022 |
3 | 1237391 | 0.021 |
6 | 845000 | 0.020 |
3 | 1726500 | 0.019 |
2 | 912000 | 0.018 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 39 | 1 |
0.024 | 141671 | 1 |
0.025 | 108920 | 2 |
0.026 | 154800 | 2 |
0.027 | 1133385 | 5 |
Last trade - 15.30pm 12/11/2024 (20 minute delay) ? |
Featured News
SEN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online